RT Journal Article
SR Electronic
T1 Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008436
DO 10.1136/jitc-2023-008436
VO 12
IS 1
A1 Huffman, Brandon M
A1 Singh, Harshabad
A1 Ali, Lestat R
A1 Horick, Nora
A1 Wang, S Jennifer
A1 Hoffman, Megan T
A1 Metayer, Katherine A
A1 Murray, Shayla
A1 Bird, Alexandra
A1 Abrams, Thomas A
A1 Biller, Leah H
A1 Chan, Jennifer A
A1 Meyerhardt, Jeffrey A
A1 McCleary, Nadine J
A1 Goessling, Wolfram
A1 Patel, Anuj K
A1 Wisch, Jeffrey S
A1 Yurgelun, Matthew B
A1 Mouw, Kent
A1 Reardon, Brendan
A1 Van Allen, Eliezer M
A1 Zerillo, Jessica A
A1 Clark, Jeffrey W
A1 Parikh, Aparna
A1 Mayer, Robert J
A1 Schlechter, Benjamin
A1 Ng, Kimmie
A1 Kumar, Sunil
A1 Del Vecchio Fitz, Catherine
A1 Kuperwasser, Charlotte
A1 Hanna, Glenn J
A1 Coveler, Andrew L
A1 Rubinson, Douglas A
A1 Welsh, Emma L
A1 Pfaff, Kathleen
A1 Rodig, Scott
A1 Dougan, Stephanie K
A1 Cleary, James M
YR 2024
UL http://jitc.bmj.com/content/12/1/e008436.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.